Stanley Druckenmiller's position in Crinetics Pharmaceuticals is currently worth $4.01 Million. That's 0.12% of their equity portfolio (63rd largest holding). Stanley Druckenmiller started to build up the position in Crinetics Pharmaceuticals in Q1 2024. Since then they sold 186 Thousand shares. The investor's estimated purchase price is $4.8 Million, resulting in a loss of 16%.